Skip to main content
. 2022 Jun 21;12:10395. doi: 10.1038/s41598-022-14573-4

Table 1.

Clinicopathologic characteristics of breast cancer patients in Southern China and SEER cohorts.

Patient characteristics Southern China SEER χ2-value P value
N (%) N (%)
Age at diagnosis (year) 0.009 0.923
Young adult group (< 40)
 < 35 38 (7.45) 1495 (2.28)
 ≥ 35 63 (12.35) 2529 (3.86)
Middle aged group (40–70) 163.919 0.000
 ≤ 48 194 (38.04) 9105 (13.89)
 > 48 202 (39.61) 32,151 (49.06)
Aged + group(> 70) 0.077 0.048
 ≤ 75 8 (1.57) 7151 (10.91)
 > 75 5 (0.98) 13,104 (20.00)
Tumor size(cm) 29.923 0.000
 Tx 10 (2.01) 51 (0.08)
 Tis 1 (0.20) 1 (0)
 Invasive group
  ≤ 2 79 (15.86) 934 (1.43)
  > 2 ≤ 5 323 (64.86) 367 (0.56)
  > 5 46 (9.24) 63 (0.1)
 Missing 39 (7.83) 64,071 (97.8)
Nodal stage 20,387.140 0.000
 pN0, no nodal metastasis 206 (40.39) 1145 (1.75)
 pN1, 1–3 nodal metastasis 132 (25.88) 222 (0.34)
 pN2, 4–9 nodal metastasis 76 (14.90) 34 (0.05)
 pN3, ≥ 10 nodal metastasis 49 (9.61) 40 (0.06)
 Unknown 47 (9.22) 64,094 (97.80)
Pathological stage 25.662 0.000
 0–1 97 (19.02) 7082 (10.82)
 2 262 (51.37) 14,936 (22.81)
 3 133 (26.08) 12,993 (19.75)
 4 18 (3.53) 1255 (1.92)
 Unknown 0 (0) 29,269 (44.7)
Estrogen receptor 106.162 0.000
 Negative 178 (34.9) 5563 (17.96)
 Positive 290 (56.86) 20,233 (65.34)
 Missing 42 (8.24) 5172 (16.70)
Progesterone receptor 30.794 0.000
 Negative 182 (35.69) 8110 (26.2)
 Positive 270 (52.94) 179,194 (55.55)
 Missing 58 (11.37) 5646 (18.24)
HER2-positive 611.595 0.000
 Negative 165 (32.35) 1530 (85.62)
 Positive 283 (55.49) 169 (9.46)
 Missing 62 (12.16) 88 (4.92)
Ki-67(%) NA NA
 < 14 100 (19.61) NA (NA)
 < 51.7 median 170 (33.33) NA (NA)
 ≥ 51.7 median 95 (18.63) NA (NA)
Missing  145(28.43) NA (NA)